Related Experiment Video
Updated: Jul 3, 2026

Practical Aspects of Sample Preparation and Setup of 1H R1ρ Relaxation Dispersion Experiments of RNA
Published on: July 9, 2021
Maintaining the silence: reflections on long-term RNAi
Koen Raemdonck1, Roosmarijn E Vandenbroucke, Joseph Demeester
1Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Harelbekestraat 72, B-9000 Ghent, Belgium.
Abstract:
Since the demonstration of RNA interference (RNAi) in mammalian cells, considerable research and financial effort has gone towards implementing RNAi as a viable therapeutic platform. RNAi is, without doubt, the most promising strategy for the treatment of human genetic disorders. Because many of the targets proposed for RNAi therapy require chronic treatment, researchers agree that the emphasis must now be placed on the safe and long-term application of RNAi drugs to reap the benefits at last.
Insights
RNA interference (RNAi) shows promise for treating genetic disorders. Future research must focus on the safe, long-term application of RNAi therapeutics for sustained patient benefit.
Area of Science:
- Biotechnology
- Molecular Biology
- Genetics
Background:
- RNA interference (RNAi) has been demonstrated in mammalian cells.
- Significant research and financial investment have been directed towards developing RNAi as a therapeutic platform.
- RNAi is considered a highly promising strategy for treating human genetic disorders.
Purpose of the Study:
- To highlight the potential of RNA interference (RNAi) as a therapeutic modality.
- To emphasize the need for a shift in research focus towards the safe and long-term application of RNAi drugs.
- To underscore the importance of addressing chronic treatment requirements for RNAi therapies.
Main Methods:
- This study is a review and perspective based on existing research in RNA interference.
- It synthesizes current understanding of RNAi technology and its therapeutic implications.
- Focuses on the strategic considerations for clinical translation.
Main Results:
- RNA interference is a leading therapeutic strategy for genetic disorders.
- The successful implementation of RNAi therapeutics necessitates a focus on long-term safety and efficacy.
- Chronic treatment paradigms are essential for many RNAi-targeted genetic conditions.
Conclusions:
- Continued development of RNAi therapeutics is crucial for treating genetic diseases.
- Prioritizing safe and long-term applications will enable RNAi to fulfill its therapeutic potential.
- Addressing the challenges of chronic RNAi drug delivery and management is paramount.
Related Concept Videos
Experimental RNAi
RNA Stability
RNA Stability
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Types of RNA
RNA Performs Diverse...
Types of RNA
RNA Performs Diverse...
